Nada M Mohamed

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Molecular Docking

Breast Cancer Cells

Neuropathic Pain

Capillary Electrophoresis

Top Venues

Future medicinal chemistry

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mona F Said, Sarah M Marie, Nada M Mohamed, Marianne Alphonse Mahrouse, Bahia A Moussa
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Future medicinal chemistry (2024)
Samir Bondock, Nada Alabbad, Aisha Hossan, Moaz M Abdou, Ali A Shati, Mohammad Y Alfaifi, Serag E I Elbehairi, Nada M Mohamed
Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics. RSC advances 14 (27) (2024)
Mingna Sun, Miada F Abdelwahab, Jianye Zhang, Mamdouh Nabil Samy, Nada M Mohamed, Islam M Abdel-Rahman, Faisal Alsenani, Usama Ramadan Abdelmohsen, Basma Khalaf Mahmoud
Cytotoxic metabolites from Sinularia levi supported by network pharmacology. PloS one 19 (2) (2024)
Mingna Sun, Miada F Abdelwahab, Jianye Zhang, Mamdouh Nabil Samy, Nada M Mohamed, Islam M Abdel-Rahman, Faisal Alsenani, Usama Ramadan Abdelmohsen, Basma Khalaf Mahmoud
Cytotoxic metabolites from Sinularia levi supported by network pharmacology. PloS one 19 (2) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Mona F Said, Sarah M Marie, Nada M Mohamed, Marianne Alphonse Mahrouse, Bahia A Moussa
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Future medicinal chemistry 16 (9) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry 16 (10) (2024)
Samir Bondock, Nada Alabbad, Aisha Hossan, Moaz M Abdou, Ali A Shati, Mohammad Y Alfaifi, Serag E I Elbehairi, Nada M Mohamed
Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics. RSC advances 14 (27) (2024)
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Future medicinal chemistry (2024)
Mona F Said, Sarah M Marie, Nada M Mohamed, Marianne Alphonse Mahrouse, Bahia A Moussa
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Future medicinal chemistry 16 (9) (2024)
Mingna Sun, Miada F Abdelwahab, Jianye Zhang, Mamdouh Nabil Samy, Nada M Mohamed, Islam M Abdel-Rahman, Faisal Alsenani, Usama Ramadan Abdelmohsen, Basma Khalaf Mahmoud
Cytotoxic metabolites from Sinularia levi supported by network pharmacology. PloS one 19 (2) (2024)
Mona F Said, Sarah M Marie, Nada M Mohamed, Marianne Alphonse Mahrouse, Bahia A Moussa
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Future medicinal chemistry 16 (9) (2024)
Mona F Said, Sarah M Marie, Nada M Mohamed, Marianne Alphonse Mahrouse, Bahia A Moussa
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Future medicinal chemistry 16 (9) (2024)
Mohammad M Al-Sanea, Tamer M Nasr, Samir Bondock, Aya Y Gawish, Nada M Mohamed
Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Samir Bondock, Tallah Albarqi, Mohamed Abboud, Tamer Nasr, Nada M Mohamed, Moaz M Abdou
Tail-approach based design, synthesis, and cytotoxic evaluation of novel disubstituted and trisubstituted 1,3-thiazole benzenesulfonamide derivatives with suggested carbonic anhydrase IX inhibition mechanism. RSC advances 13 (34) (2023)
Mohammad M Al-Sanea, Tamer M Nasr, Samir Bondock, Aya Y Gawish, Nada M Mohamed
Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Nourhan Hisham Shady, Abdullah H Altemani, Faisal H Altemani, Sherif A Maher, Mahmoud A Elrehany, Entesar Ali Saber, Ahmed M Badawi, Fatma Mohamed Abd El-Mordy, Nada M Mohamed, Mohammad A S Abourehab, Ahmed M Sayed, Usama Ramadan Abdelmohsen, Soad A Mohamad
The Potential of Corchorus olitorius Seeds Buccal Films for Treatment of Recurrent Minor Aphthous Ulcerations in Human Volunteers. Molecules (Basel, Switzerland) 27 (20) (2022)
Kamilia M Amin, Gehan H Hegazy, Riham F George, Nahla R Ibrahim, Nada M Mohamed
Design, synthesis, and pharmacological characterization of some 2-substituted-3-phenyl-quinazolin-4(3H)-one derivatives as phosphodiesterase inhibitors. Archiv der Pharmazie 354 (9) (2021)
Nada M Mohamed, Eslam M H Ali, Asmaa M AboulMagd
Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 M pro inhibitors. RSC advances 11 (8) (2021)
Kamilia M Amin, Aly M Taha, Riham F George, Nada M Mohamed, Fardous F Elsenduny
Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents. Archiv der Pharmazie 351 (1) (2017)